寶蘭德(688058.SH):兩名股東承諾六個月內不減持公司股份
格隆匯3月15日丨寶蘭德(688058.SH)公佈,公司於2021年3月15日收到股東趙雪、王茜《關於本人股份鎖定的承諾》,分別承諾自2021年3月15日起6個月內,不轉讓或者委託他人管理其直接或間接持有的寶蘭德公開發行股票前已發行的股份,也不由寶蘭德回購其直接或間接持有的寶蘭德公開發行股票前已發行的股份。
其中,趙雪持有股份103.2萬股,持股比例2.58%;王茜持有股份129萬股,持股比例3.23%。截至本公吿披露日,上述股東均未減持股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.